Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2020-07-23 | 2020-09-01 | 120964 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2020-07-23 | 2021-05-17 | 120971 |
APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2020-07-23 | 2020-08-07 | 120979 |
APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-07-23 | 2020-11-16 | 120982 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-23 | 2020-09-04 | 120985 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-07-23 | 2020-08-10 | 120988 |
ANAFRANIL | 25MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 121017 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2020-07-24 | 2021-01-19 | 121090 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-08-07 | 121322 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-07-30 | 121325 |
APO-LISINOPRIL | 20MG | TABLET | Resolved | 2020-07-29 | 2020-10-05 | 121328 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2020-07-29 | 2020-08-05 | 121331 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121334 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121337 |
APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2020-07-29 | 2020-09-04 | 121340 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-29 | 2020-09-21 | 121343 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2020-08-05 | 2020-09-14 | 121768 |
APO-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Resolved | 2020-08-06 | 2020-11-28 | 121891 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2020-08-06 | 2020-09-28 | 121894 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2020-08-06 | 2020-11-23 | 121897 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |